Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Glossopharyngeal Nerve Stimulation. Edition No. 1

VDM Publishing House, April 2009, Pages: 80


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

To date, no detailed study has explored the potential
for stimulation of cranial nerves other than the
vagus nerve for medically intractable seizures.
Medically intractable epilepsy causes significant
morbidity and mortality. While several medical
therapies for this disease have been developed, each
can be associated with significant adverse effects.
In the United States approximately 30,000 new cases
of medically intractable epilepsy are diagnosed each
year, and only 15% of these patients can be treated
by neurosurgical procedures. Many patients have had
success with stimulation of the vagus nerve. However,
some patients do not respond to vagus nerve
stimulation. The hypothesis tested in the following
four studies is that glossopharyngeal nerve
stimulation can provide adequate seizure control with
fewer adverse results. The results of this study may
elucidate both the effectiveness and underlying
mechanisms by which glossopharyngeal nerve
stimulation leads to blunting of seizure activity.
Thus, this study lays the groundwork for development
of a potentially effective method to treat many
patients who currently lack effective antiseizure
therapy.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds